...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Influence of Chongcao Yigan Capsule on Function of Intestinal Flora and Chemoprevention for Patients with Chronic Hepatitis B-Induced Liver Fibrosis
【24h】

Influence of Chongcao Yigan Capsule on Function of Intestinal Flora and Chemoprevention for Patients with Chronic Hepatitis B-Induced Liver Fibrosis

机译:Chongcao Yigan胶囊对慢性乙型肝炎肝纤维化患者肠道植物和化学预防功能的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Hapatitis B visus (CHB)-induced fibrosis is a precancerous condition of liver. To explore the influence of Chongcao Preparation (Chongcao Yigan Capsule) on the function of intestinal flora and chemoprevention for patients with CHB-induced liver fibrosis. A total of 136 patients with CHB-induced liver fibrosis were randomly divided into control group treated with lamivudine (LAM) and research group added with Chongcao Yigan Capsule for totally 48 weeks. The changes of intestinal flora, secretory immunoglobin A (SIgA), serum albumin (ALB), prealbumin (PALB), IgA and IgG at different time points in both groups were observed. Before treatment, there was no significant difference between two groups in each index (P0.05). After treatment, the intestinal flora were evidently optimized in research group than treatment before (P0.05 or P0.01), and were apparently better than those in control group (P0.05 or P0.01); SIgA was obviously increased and ALB, PALB, IgA and IgG were markedly improved in research group than treatment before (P0.05 or P0.01), and were significantly better than those in control group (P0.05 or P0.01). Chongcao Yigan Capsule could regulate the intestinal flora, increase SIgA, serum ALB and PALB concentrations and significantly improve serum IgA and IgG as well as strengthen the immunological function and autologous repair capacity of patients with CHB-induced liver fibrosis.
机译:Hapatitis乙visus(CHB)诱导的纤维化是肝脏的癌前状态。探讨虫草准备(虫草益肝胶囊)对肠道菌群和化学预防的慢性乙肝患者,肝纤维化作用的影响。与CHB诱导的肝纤维化总共136名患者随机分为拉米夫定(LAM)处理的对照组和研究组虫草益肝胶囊增加了对完全48周。肠道菌群,分泌免疫球蛋白A(SIgA的),血清白蛋白(ALB),前白蛋白(PALB)的变化,观察到IgA和IgG在两组不同的时间点。治疗前,有在每个指数(P> 0.05),两组之间没有差异显著。处理后,将肠道菌群在比治疗研究组明显优化之前(P <0.05或p <0.01),并且是明显优于对照组(P <0.05或p <0.01); SIgA的明显提高和ALB,PALB,IgA和IgG均明显比治疗研究组之前(或P <0.01 P <0.05)的提高,并且是显著优于对照组(P <0.05或p <0.01)。虫草益肝胶囊可调节肠道菌群,增加的SIgA,血清白蛋白和PALB浓度显著提高血清IgA和IgG以及增强免疫功能及患者的自体修复能力与慢性乙肝引起的肝纤维化。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号